Stock NGNE NEUROGENE INC.
Add to a list
To use this feature you must be a member
Log inSign up

Charts Neurogene Inc.

Equities

NGNE

US64135M1053

Market Closed - Nasdaq
Other stock markets
 04:00:00 2024-05-31 pm EDT 		5-day change 1st Jan Change
37.6 USD +10.10% Intraday chart for Neurogene Inc. +17.10% +94.01%
May. 10 Neurogene Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
May. 07 Neurogene Presents Favorable Safety Data from Phase 1/2 Trial of Ngn-401 Gene Therapy for Rett Syndrome During Asgct Annual Meeting CI

Chart: Technical Analysis

Technical analysis trends

Short TermMid-TermLong Term
Trend

Neutral

Bullish

Neutral

Resistance 36.63 50.90 50.90
Spread/Res.+2.65%-26.13%-26.13%
Spread/Supp.+29.03%+29.03%+27.63%
Support 29.14 29.14 29.46

Technical Rankings Surperformance

Short Term Timing
Middle Term Timing
Long Term Timing
RSI
Bollinger Spread
Unusual Volumes
  1. Stock Market
  2. Equities
  3. NGNE Stock
  4. Charts Neurogene Inc.